Thymosin α1: Burying secrets in the thymus

Expert Opinion on Biological Therapy

Volumn 15, Issue , 2015, Pages 51-58

  Moretti, Silvia ^a   Oikonomou, Vasileios ^a   Garaci, Enrico ^b   Romani, Luigina ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

3 dioxygenase; Autoimmune regulator; Immune tolerance; Indoleamine 2; Thymosin 1

Indexed keywords

AUTOIMMUNE REGULATOR PROTEIN; INDOLEAMINE 2,3 DIOXYGENASE; LEGUMAIN; THYMOSIN ALPHA1; THYMOSIN; TRANSCRIPTION FACTOR;

CATABOLISM; CELL DIFFERENTIATION; CELL PROLIFERATION; DENDRITIC CELL; EDITORIAL; EPITHELIUM CELL; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; NONHUMAN; PLEIOTROPY; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; THYMUS; TRANSCRIPTION REGULATION; ANALOGS AND DERIVATIVES; ANIMAL; AUTOIMMUNITY; BIOSYNTHESIS; IMMUNOLOGY; METABOLISM;

ANIMALS; AUTOIMMUNITY; DENDRITIC CELLS; HUMANS; IMMUNE TOLERANCE; T-LYMPHOCYTES, REGULATORY; THYMOSIN; THYMUS GLAND; TRANSCRIPTION FACTORS;

EID: 84957791934     PISSN: 14712598     EISSN: 17447682     Source Type: Journal    
DOI: 10.1517/14712598.2015.1044895     Document Type: Editorial

References (43)

1. Goldstein AL, Goldstein AL. From lab to bedside: emerging clinical applications of thymosin alpha 1. Expert Opin Biol Ther 2009;9:593-608
2. Garaci E. Thymosin alpha1: a historical overview. Ann N Y Acad Sci 2007;1112:14-20
3. Weller FE, Shah U, Cummings GD, et al. Serum levels of immunoreactive thymosin alpha 1 and thymosin beta 4 in large cohorts of healthy adults. Thymus 1992;19:45-52
4. Billich A. Thymosin alpha1. SciClone Pharmaceuticals. Curr Opin Investig Drugs 2002;3:698-707
5. Tuthill CW, King RS. Thymosin Apha 1--A Peptide Immune Modulator with a Broad Range of Clinical Applications. Clin Exp Pharmacol 2013;3:133
6. Romani L, Bistoni F, Gaziano R, et al. Thymosin alpha 1 activates dendritic cells for antifungal Th1 resistance through toll-like receptor signaling. Blood 2004;103:4232-9
7. Zhang P, Chan J, Dragoi AM, et al. Activation of IKK by thymosin alpha1 requires the TRAF6 signalling pathway. EMBO Rep 2005;6:531-7
8. Romani L, Bistoni F, Perruccio K, et al. Thymosin alpha1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance. Blood 2006;108:2265-74
9. Pierluigi BD, Angelo C, Fallarino F, et al. Thymosin alpha1: the regulator of regulators? Ann N Y Acad Sci 2010;1194:1-5
10. Romani L, Moretti S, Fallarino F, et al. Jack of all trades: thymosin alpha1 and its pleiotropy. Ann N Y Acad Sci 2012;1269:1-6
11. Bozza S, Gaziano R, Bonifazi P, et al. Thymosin alpha1 activates the TLR9/MyD88/IRF7-dependent murine cytomegalovirus sensing for induction of anti-viral responses in vivo. Int Immunol 2007;19:1261-70
12. Romani L, Bistoni F, Montagnoli C, et al. Thymosin alpha1: an endogenous regulator of inflammation immunity and tolerance. Ann N Y Acad Sci 2007;1112:326-38
13. Bonizzi G, Karin M. The two NFkappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 2004;25:280-8
14. Medzhitov R, Schneider DS, Soares MP. Disease tolerance as a defense strategy. Science 2012;335:936-41
15. Hooper LV, Macpherson AJ. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol 2010;10:159-69
16. Thorburn AN, Macia L, Mackay CR. Diet metabolites and “western-lifestyle” inflammatory diseases. Immunity 2014;40:833-42
17. Bollrath J, Powrie FM. Controlling the frontier: regulatory T-cells and intestinal homeostasis. Semin Immunol 2013;25:352-7
18. Roncarolo MG, Gregori S, Bacchetta R, et al. Tr1 cells and the counterregulation of immunity: natural mechanisms and therapeutic applications. Curr Top Microbiol Immunol 2014;380:39-68
19. Shevach EM, Thornton AM. tTregs, pTregs, and iTregs: similarities and differences. Immunol Rev 2014;259:88-102
20. Puccetti P, Grohmann U. IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB activation. Nat Rev Immunol 2007;7:817-23
21. McGaha TL, Huang L, Lemos H, et al. Amino acid catabolism: a pivotal regulator of innate and adaptive immunity. Immunol Rev 2012;249:135-57
22. Munn DH, Mellor AL. Indoleamine 23 dioxygenase and metabolic control of immune responses. Trends Immunol 2013;34:137-43
23. Finnish-German AC. An autoimmune disease APECED caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet 1997;17:399-403
24. Nagamine K, Peterson P, Scott HS, et al. Positional cloning of the APECED gene. Nat Genet 1997;17:393-8
25. Mittaz L, Rossier C, Heino M, et al. Isolation and characterization of the mouse AIRE gene. Biochem Biophys Res Commun 1999;255:483-90
26. Peterson P, Org T, Rebane A. Transcriptional regulation by AIRE: molecular mechanisms of central tolerance. Nat Rev Immunol 2008;8:948-57
27. Derbinski J, Gabler J, Brors B, et al. Promiscuous gene expression in thymic epithelial cells is regulated at multiple levels. J Exp Med 2005;202:33-45
28. Mathis D, Benoist C. Aire. Annu Rev Immunol 2009;27:287-312
29. Metzger TC, Anderson MS. Control of central and peripheral tolerance by Aire. Immunol Rev 2011;241:89-103
30. Anderson MS, Venanzi ES, Klein L, et al. Projection of an immunological self shadow within the thymus by the aire protein. Science 2002;298:1395-401
31. Poliani PL, Kisand K, Marrella V, et al. Human peripheral lymphoid tissues contain autoimmune regulator-expressing dendritic cells. Am J Pathol 2010;176:1104-12
32. Gardner JM, Devoss JJ, Friedman RS, et al. Deletional tolerance mediated by extrathymic Aire-expressing cells. Science 2008;321:843-7
33. Naruse H, Hashimoto T, Yamakawa Y, et al. Immunoreactive thymosin alpha 1 in human thymus and thymoma. J Thorac Cardiovasc Surg 1993;106:1065-71
34. Dalakas MC, Engel WK, McClure JE, et al. Immunocytochemical localization of thymosin-alpha 1 in thymic epithelial cells of normal and myasthenia gravis patients and in thymic cultures. J Neurol Sci 1981;50:239-47
35. Watanabe N, Wang YH, Lee HK, et al. Hassall’s corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus. Nature 2005;436:1181-5
36. Watanabe N, Hanabuchi S, Soumelis V, et al. Human thymic stromal lymphopoietin promotes dendritic cellmediated CD4+ T cell homeostatic expansion. Nat Immunol 2004;5:426-34
37. Roan F, Bell BD, Stoklasek TA, et al. The multiple facets of thymic stromal lymphopoietin (TSLP) during allergic inflammation and beyond. J Leukoc Biol 2012;91:877-86
38. Sarandeses CS, Covelo G, Diaz-Jullien C, et al. Prothymosin alpha is processed to thymosin alpha 1 and thymosin alpha 11 by a lysosomal asparaginyl endopeptidase. J Biol Chem 2003;278:13286-93
39. Ahlgren KM, Moretti S, Lundgren BA, et al. Increased IL-17A secretion in response to Candida albicans in autoimmune polyendocrine syndrome type 1 and its animal model. Eur J Immunol 2011;41:235-45
40. Zelante T, Iannitti RG, Cunha C, et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 2013;39:372-85
41. Sillanpaa N, Magureanu CG, Murumagi A, et al. Autoimmune regulator induced changes in the gene expression profile of human monocytedendritic cell-lineage. Mol Immunol 2004;41:1185-98
42. de Luca A, Bozza S, Zelante T, et al. Non-hematopoietic cells contribute to protective tolerance to Aspergillus fumigatus via a TRIF pathway converging on IDO. Cell Mol Immunol 2010;7:459-70
43. De Luca A, Montagnoli C, Zelante T, et al. Functional yet balanced reactivity to Candida albicans requires TRIF, MyD88, and IDO-dependent inhibition of Rorc. J Immunol 2007;179:5999-6008